When the aMCI patients were divided into the low and high PRSsMDD groups, the high PRSsMDD group (65.38%) showed 16.25% higher conversion rate than the low PRSsMDD group (49.13%) (P = 0.002). When patients were divided into the double low risk group, low PRSsAD but high PRSsMDD group, high PRSsAD but low PRSsMDD group, and double high risk group. There were significant differences in the conversion rate of the aMCI among these hierarchical PRS groups (P = 4.26 × 10−7). In the low PRSsAD group, the aMCI patients with high PRSsMDD showed marginally higher conversion rate than those with low PRSsMDD (36.84% versus 51.81%, P = 0.05). In the high PRSsAD group, the aMCI patients with high PRSsMDD showed significantly higher conversion rate than those with low PRSsMDD (63.21% versus 80.26%, P = 0.002) (Fig. 2I and Table 3). When PRSsMDD and PRSsAD were trisected into the low, middle and high risk, there were significant differences in conversion rate among the nine hierarchical PRS groups (P = 3.23 × 10−6) (Supplementary materials andSupplementary Table 6).
PRS groups . | aMCI-S, n . | aMCI-C, n . | Conversion rate, % . |
---|---|---|---|
Low PRSsAD and low PRSsMDD | 48 | 28 | 36.84 |
Low PRSsAD and high PRSsMDD | 40 | 43 | 51.81 |
High PRSsAD and low PRSsMDD | 32 | 55 | 63.21 |
High PRSsAD and high PRSsMDD | 15 | 61 | 80.26 |
All | 135 | 187 | 58.07 |
PRS groups . | aMCI-S, n . | aMCI-C, n . | Conversion rate, % . |
---|---|---|---|
Low PRSsAD and low PRSsMDD | 48 | 28 | 36.84 |
Low PRSsAD and high PRSsMDD | 40 | 43 | 51.81 |
High PRSsAD and low PRSsMDD | 32 | 55 | 63.21 |
High PRSsAD and high PRSsMDD | 15 | 61 | 80.26 |
All | 135 | 187 | 58.07 |
PRS groups . | aMCI-S, n . | aMCI-C, n . | Conversion rate, % . |
---|---|---|---|
Low PRSsAD and low PRSsMDD | 48 | 28 | 36.84 |
Low PRSsAD and high PRSsMDD | 40 | 43 | 51.81 |
High PRSsAD and low PRSsMDD | 32 | 55 | 63.21 |
High PRSsAD and high PRSsMDD | 15 | 61 | 80.26 |
All | 135 | 187 | 58.07 |
PRS groups . | aMCI-S, n . | aMCI-C, n . | Conversion rate, % . |
---|---|---|---|
Low PRSsAD and low PRSsMDD | 48 | 28 | 36.84 |
Low PRSsAD and high PRSsMDD | 40 | 43 | 51.81 |
High PRSsAD and low PRSsMDD | 32 | 55 | 63.21 |
High PRSsAD and high PRSsMDD | 15 | 61 | 80.26 |
All | 135 | 187 | 58.07 |
Top 10 neighbouring genes of the PPI network from PRSsMDD fine-mapping of 1860 genes and PRSsMDD fine-mapping of 1608 genes
Ranking . | PRSsMDD fine-mapping of 1860 genesa . | PRSsMDD fine-mapping of 1608 genesb . | ||
---|---|---|---|---|
Gene symbol . | Random walk probability . | Gene symbol . | Random walk probability . | |
1 | APP | 6.84 × 10−3 | APP | 6.78 × 10−3 |
2 | ELAVL1 | 4.49 × 10−3 | ELAVL1 | 4.49 × 10−3 |
3 | NTRK1 | 2.21 × 10−3 | NXF1 | 2.25 × 10−3 |
4 | NXF1 | 2.03 × 10−3 | NTRK1 | 2.17 × 10−3 |
5 | CUL3 | 1.70 × 10−3 | CUL3 | 1.71 × 10−3 |
6 | MOV10 | 1.50 × 10−3 | MOV10 | 1.50 × 10−3 |
7 | TP53 | 1.45 × 10−3 | UBC | 1.46 × 10−3 |
8 | EWSR1 | 1.43 × 10−3 | TR53 | 1.32 × 10−3 |
9 | UBC | 1.42 × 10−3 | EWSR1 | 1.19 × 10−3 |
10 | TMEM17 | 1.33 × 10−3 | COPS5 | 1.17 × 10−3 |
Ranking . | PRSsMDD fine-mapping of 1860 genesa . | PRSsMDD fine-mapping of 1608 genesb . | ||
---|---|---|---|---|
Gene symbol . | Random walk probability . | Gene symbol . | Random walk probability . | |
1 | APP | 6.84 × 10−3 | APP | 6.78 × 10−3 |
2 | ELAVL1 | 4.49 × 10−3 | ELAVL1 | 4.49 × 10−3 |
3 | NTRK1 | 2.21 × 10−3 | NXF1 | 2.25 × 10−3 |
4 | NXF1 | 2.03 × 10−3 | NTRK1 | 2.17 × 10−3 |
5 | CUL3 | 1.70 × 10−3 | CUL3 | 1.71 × 10−3 |
6 | MOV10 | 1.50 × 10−3 | MOV10 | 1.50 × 10−3 |
7 | TP53 | 1.45 × 10−3 | UBC | 1.46 × 10−3 |
8 | EWSR1 | 1.43 × 10−3 | TR53 | 1.32 × 10−3 |
9 | UBC | 1.42 × 10−3 | EWSR1 | 1.19 × 10−3 |
10 | TMEM17 | 1.33 × 10−3 | COPS5 | 1.17 × 10−3 |
aPRSsMDD genetic variants were fine-mapped into 1860 genes based on the hippocampal-specific regulatory probability between eQTLs and epigenomic features (within a 5-kb window).
bPRSsMDD genetic variants were fine-mapped into 1608 genes based on physical position of each variant (within a 5-kb window).
The abbreviation of genes is referred to at https://www.ncbi.nlm.nih.gov/gene/.
Top 10 neighbouring genes of the PPI network from PRSsMDD fine-mapping of 1860 genes and PRSsMDD fine-mapping of 1608 genes
Ranking . | PRSsMDD fine-mapping of 1860 genesa . | PRSsMDD fine-mapping of 1608 genesb . | ||
---|---|---|---|---|
Gene symbol . | Random walk probability . | Gene symbol . | Random walk probability . | |
1 | APP | 6.84 × 10−3 | APP | 6.78 × 10−3 |
2 | ELAVL1 | 4.49 × 10−3 | ELAVL1 | 4.49 × 10−3 |
3 | NTRK1 | 2.21 × 10−3 | NXF1 | 2.25 × 10−3 |
4 | NXF1 | 2.03 × 10−3 | NTRK1 | 2.17 × 10−3 |
5 | CUL3 | 1.70 × 10−3 | CUL3 | 1.71 × 10−3 |
6 | MOV10 | 1.50 × 10−3 | MOV10 | 1.50 × 10−3 |
7 | TP53 | 1.45 × 10−3 | UBC | 1.46 × 10−3 |
8 | EWSR1 | 1.43 × 10−3 | TR53 | 1.32 × 10−3 |
9 | UBC | 1.42 × 10−3 | EWSR1 | 1.19 × 10−3 |
10 | TMEM17 | 1.33 × 10−3 | COPS5 | 1.17 × 10−3 |
Ranking . | PRSsMDD fine-mapping of 1860 genesa . | PRSsMDD fine-mapping of 1608 genesb . | ||
---|---|---|---|---|
Gene symbol . | Random walk probability . | Gene symbol . | Random walk probability . | |
1 | APP | 6.84 × 10−3 | APP | 6.78 × 10−3 |
2 | ELAVL1 | 4.49 × 10−3 | ELAVL1 | 4.49 × 10−3 |
3 | NTRK1 | 2.21 × 10−3 | NXF1 | 2.25 × 10−3 |
4 | NXF1 | 2.03 × 10−3 | NTRK1 | 2.17 × 10−3 |
5 | CUL3 | 1.70 × 10−3 | CUL3 | 1.71 × 10−3 |
6 | MOV10 | 1.50 × 10−3 | MOV10 | 1.50 × 10−3 |
7 | TP53 | 1.45 × 10−3 | UBC | 1.46 × 10−3 |
8 | EWSR1 | 1.43 × 10−3 | TR53 | 1.32 × 10−3 |
9 | UBC | 1.42 × 10−3 | EWSR1 | 1.19 × 10−3 |
10 | TMEM17 | 1.33 × 10−3 | COPS5 | 1.17 × 10−3 |
aPRSsMDD genetic variants were fine-mapped into 1860 genes based on the hippocampal-specific regulatory probability between eQTLs and epigenomic features (within a 5-kb window).
bPRSsMDD genetic variants were fine-mapped into 1608 genes based on physical position of each variant (within a 5-kb window).
The abbreviation of genes is referred to at https://www.ncbi.nlm.nih.gov/gene/.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.